Home Tags Epidermal Growth Factor Receptor

Tag: Epidermal Growth Factor Receptor

Depatuxizumab Mafodotin Did Not Demonstrate Survival Benefit in INTELLANCE-1 Study

Depatuxizumab mafodotin (also known as Depatux-M, and previously known as ABT-414), an antibody-drug conjugate (ADC) being developed by AbbVie, did not demonstrate a survival...

Amgen and CytomX Therapeutics Agree to Jointly Develop T-Cell Engaging Bispecific...

Amgen and CytomX Therapeutics have entered into a strategic collaboration to co-develop a Probody™ T-cell engaging bispecific against the Epidermal Growth Factor Receptor (EGFR),...

X